Clinical effectiveness of neuraminidase inhibitors—oseltamivir, zanamivir, laninamivir, and peramivir—for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010–2011 influenza season in Japan

World Health Organization. Influenza (seasonal). Fact sheet N°211. http://www.who.int/mediacentre/factsheets/fs211/en/; c2011. Updated in Apr 2009, cited 2012 Jan 10. 2011, Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011, MMWR Morb Mortal Wkly Rep, 60, 1128 Jefferson, 2010, Neuraminidase inhibitors for preventing and treating influenza in healthy adults, Cochrane Database Syst Rev, 2010, 10.1002/14651858.CD001269.pub4 Schirmer, 2009, Oseltamivir for treatment and prophylaxis of influenza infection, Expert Opin Drug Saf, 8, 357, 10.1517/14740330902840519 Sugaya, 2011, Widespread use of neuraminidase inhibitors in Japan, J Infect Chemother, 17, 595, 10.1007/s10156-011-0288-0 Kohno, 2010, Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection, Antimicrob Agents Chemother, 54, 4568, 10.1128/AAC.00474-10 Kohno, 2011, Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection, Antimicrob Agents Chemother, 55, 5267, 10.1128/AAC.00360-11 Sugaya, 2012, Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection, Antimicrob Agents Chemother, 56, 369, 10.1128/AAC.00132-11 Sugaya, 2010, Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection, Antimicrob Agents Chemother, 54, 2575, 10.1128/AAC.01755-09 Watanabe, 2010, Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial, Clin Infect Dis, 51, 1167, 10.1086/656802 Nakauchi, 2011, One-step real-time reverse transcription-PCR assays for detecting and subtyping pandemic influenza A/H1N1 2009, seasonal influenza A/H1N1, and seasonal influenza A/H3N2 viruses, J Virol Methods, 171, 156, 10.1016/j.jviromet.2010.10.018 Suzuki, 2011, Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method, J Clin Microbiol, 49, 125, 10.1128/JCM.01401-10 Kawai, 2009, Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007–2008 and 2008–2009 influenza seasons, Clin Infect Dis, 49, 1828, 10.1086/648424 Kawai, 2011, Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007–2008 and 2008–2009 seasons, J Infect Chemother, 17, 375, 10.1007/s10156-010-0179-9 Sugaya, 2008, Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children, Clin Infect Dis, 47, 339, 10.1086/589748 Saito, 2010, Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation, Pediatr Infect Dis J, 29, 898, 10.1097/INF.0b013e3181de9d24 Ishizuka, 2010, Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers, J Clin Pharmacol, 50, 1319, 10.1177/0091270009356297 Baranovich, 2010, Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008–2009 season, J Clin Virol, 47, 23, 10.1016/j.jcv.2009.11.003 Zaraket, 2011, Genetic diversity and antiviral drug resistance of pandemic H1N1 2009 in Lebanon, J Clin Virol, 51, 170, 10.1016/j.jcv.2011.04.001 Ujike, 2011, Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009–2010, Emerg Infect Dis, 17, 470, 10.3201/eid1703.101188 Renaud, 2011, Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1, J Clin Virol, 52, 70, 10.1016/j.jcv.2011.05.019 Thorlund, 2011, Systematic review of influenza resistance to the neuraminidase inhibitors, BMC Infect Dis, 11, 134, 10.1186/1471-2334-11-134